Flare Therapeutics

📍 Cambridge, United States🗓 Founded 2021👥 50 employees💰 Last funded May 2021
Biotechnology Research🌐 flaretx.com
Website LinkedIn
Our team ‘brings it’ every day for one mission: to conquer transcription factors and create cutting-edge medicines for patients. Flare is lighting up a new therapeutic space with an entirely different approach to decipher the biology of transcription factors to develop small molecule medicines. Based on insights from the seminal work of our scientific founders, Flare’s team is leveraging the power of ‘switch sites’ as druggable regions that hold the control for predictable and profound changes in DNA transcription, and therefore, gene expression. Our drug discovery to target ‘switch sites’ has rapidly advanced, resulting in our pipeline of drug programs that address well-validated transcription factors, initially focused on precision oncology.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2021
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
1
Frequently asked questions
Who invested in Flare Therapeutics?
Flare Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Flare Therapeutics last raise funding?
The most recent investment in Flare Therapeutics recorded on gritt.io was in May 2021.
When was Flare Therapeutics founded?
Flare Therapeutics was founded in 2021.
What industry is Flare Therapeutics in?
Flare Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Flare Therapeutics based?
Flare Therapeutics is headquartered in Cambridge, United States.